NTRR
NEUTRA CORP.
Key Financials
Gross Profit
$35306
↑ 13.3%
Net Income
$-561417
↑ 11.3%
Operating Income
$-297675
↑ 49.0%
Revenue
$67996
↓ 26.1%
Total Liabilities
$813795.00
↓ 29.5%
Total Assets
$75175.00
↓ 42.6%
Shareholders' Equity
$-773820.00
↑ 39.2%
Cash & Equivalents
$1969.00
↑ 86.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 15-12G | 12/12/2024 | View on SEC |
| 10-Q | 8/7/2024 | View on SEC |
| 10-K | 8/2/2024 | View on SEC |
| NT 10-Q | 6/17/2024 | View on SEC |
| 8-K | 5/15/2024 | View on SEC |
| NT 10-K | 4/30/2024 | View on SEC |
| 10-Q | 12/15/2023 | View on SEC |
| 10-Q | 9/14/2023 | View on SEC |
| 8-K | 8/4/2023 | View on SEC |
| 10-Q | 6/22/2023 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NTRR |
| Company Name | NEUTRA CORP. |
| CIK | 1512886 |
| Sector | Medicinal Chemicals & Botanical Products |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2833 |
| SIC Description | Medicinal Chemicals & Botanical Products |
| Entity Type | operating |
| Fiscal Year End | 0131 |
| State of Incorporation | WY |
| Phone | (307) 228-1488 |